Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study

Conclusions:
Liraglutide decreases carotid IMT after 8 months treatment independently of its effect on plasma glucose and lipids concentrations.Trial registration: ClinicalTrials.gov: NCT01715428.

Source: Cardiovascular Diabetology - February 22, 2014 Category: Cardiology Authors: Manfredi RizzoManisha ChandaliaAngelo PattiVittoria Di BartoloAli RizviGiuseppe MontaltoNicola Abate Source Type: research